 |
인쇄하기
취소
|
Roche's Fuzeon will not be discussed in health insurance meeting next month
Roche Korea's anti-AIDS agent Fuzeon (enfuvirtide) will be exclusive from the government's health insurance meeting to be held next month, according to the Ministry of Health and Welfare.
The ministry officials said that Fuzeon may be replaced by other medicines in combating drug resistance in AIDS patients.
In 2004, the Health Insurance Review Agency decided to get Fuzeon listed in healt...
The ministry officials said that Fuzeon may be replaced by other medicines in combating drug resistance in AIDS patients.
In 2004, the Health Insurance Review Agency decided to get Fuzeon listed in healt...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.